129 related articles for article (PubMed ID: 21804377)
21. Ivabradine: beyond heart rate control.
Riccioni G; Vitulano N; D'Orazio N
Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
[TBL] [Abstract][Full Text] [Related]
22. Heart rate as a treatable cardiovascular risk factor.
Tardif JC
Br Med Bull; 2009; 90():71-84. PubMed ID: 19474056
[TBL] [Abstract][Full Text] [Related]
23. Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris.
Vliegen HW; van der Wall EE; Niemeyer MG; Holwerda NJ; Bernink PJ; de Weerd P; Bosma AH; van der Wieken LR; Timmermans AJ; Molhoek GP
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S55-60. PubMed ID: 1725545
[TBL] [Abstract][Full Text] [Related]
24. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.
Rosano GM; Vitale C; Volterrani M
Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895
[TBL] [Abstract][Full Text] [Related]
25. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
[TBL] [Abstract][Full Text] [Related]
26. [ProCor: an extramural screening on heart rate reduction in patients with chronic stable angina pectoris in Austria].
Badr Eslam R; Siostrzonek P; Eber B; Podczeck-Schweighofer A; Lang I
Wien Klin Wochenschr; 2010 Aug; 122(15-16):486-93. PubMed ID: 20689996
[TBL] [Abstract][Full Text] [Related]
27. Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis.
Bangalore S; Parkar S; Messerli FH
Am J Med; 2009 Apr; 122(4):356-65. PubMed ID: 19332231
[TBL] [Abstract][Full Text] [Related]
28. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
[TBL] [Abstract][Full Text] [Related]
29. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials.
Cucherat M
Eur Heart J; 2007 Dec; 28(24):3012-9. PubMed ID: 17981830
[TBL] [Abstract][Full Text] [Related]
30. [New opportunities to improve the treatment effectiveness of patients with stable angina].
Grigoryeva NY; Vilkova OE; Samolyuk MO; Kolosova KS
Kardiologiia; 2020 Jul; 60(6):1135. PubMed ID: 32720615
[TBL] [Abstract][Full Text] [Related]
31. Rate control with ivabradine: angina pectoris and beyond.
Parakh N; Bhargava B
Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
[TBL] [Abstract][Full Text] [Related]
32. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
[TBL] [Abstract][Full Text] [Related]
33. Inadequate heart rate control is associated with worse quality of life in patients with coronary artery disease and chronic obstructive pulmonary disease. The RYTHMOS study.
Andrikopoulos G; Pastromas S; Kartalis A; Toli K; Mantas I; Tzeis S; Kyrpizidis C; Olympios C; Manolis AJ; Foussas S; Kranidis A; Pras A; Pipilis A; Chryssos D; Gotsis A; Trikas A; Richter D; Alexopoulos D; Parthenakis F; Theodorakis G; Konstantinides S; Vardas P
Hellenic J Cardiol; 2012 Mar; 53(2):118-26. PubMed ID: 22484777
[TBL] [Abstract][Full Text] [Related]
34. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
35. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
Picano E;
Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
[TBL] [Abstract][Full Text] [Related]
36. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.
Diaz A; Bourassa MG; Guertin MC; Tardif JC
Eur Heart J; 2005 May; 26(10):967-74. PubMed ID: 15774493
[TBL] [Abstract][Full Text] [Related]
37. Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.
Zhu H; Xu X; Fang X; Zheng J; Zhao Q; Chen T; Huang J
Clin Ther; 2019 Oct; 41(10):2137-2152.e12. PubMed ID: 31548105
[TBL] [Abstract][Full Text] [Related]
38. Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease.
Jochmann N; Schröter F; Knebel F; Hättasch R; Gericke C; Stangl K; Baumann G; Stangl V
Cardiovasc Ultrasound; 2014 Jan; 12():5. PubMed ID: 24479706
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of a rate control protocol for cardiac CT.
Roberts WT; Wright AR; Timmis JB; Timmis AD
Br J Radiol; 2009 Apr; 82(976):267-71. PubMed ID: 19098083
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of metoprolol versus diltiazem for rate control of atrial fibrillation in the emergency department.
McGrath P; Kersten B; Chilbert MR; Rusch C; Nadler M
Am J Emerg Med; 2021 Aug; 46():585-590. PubMed ID: 33257143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
